Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Granulocyte Colony-Stimulating Factor Starting at 24 Hours vs 72 Hours in Pediatric Oncology Patients

NCT03823950 is registered in ClinicalTrials.gov with University of Mississippi Medical Center as lead sponsor.

NCT NCT03823950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03823950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Granulocyte Colony-Stimulating Factor Starting at 24 Hours vs 72 Hours in Pediatric Oncology Patients
Lead sponsor
University of Mississippi Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
February 1, 2019
Completion date
June 30, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced febrile neutropenia, chemotherapy-induced neutropenia, granulocyte colony-stimulating factor, pediatric cancer